ERBB2 and breast cancer: Previous whole genome sequencing (WGS) of mouse models has revealed important human disease parallels, with sequencing of the MMTV-Neu mouse model revealing a conserved coamplification event that exists in 25% of human HER2+ breast cancers and 9% of all breast cancers.